Laboratory survey and literature review of anaerobic bacteriology: foundations of a clinically orientated and evidence-based workup for anaerobic cultures.

Since the introduction of matrix-assisted laser desorption ionization mass spectrometry time-of-flight (MALDI-TOF MS) in the routine microbiology laboratory, identification of anaerobic bacteria has become easier. This increases the possibility of new challenges for analysis and reporting of inspection anaerobes. In February 2015, a comprehensive web-based survey about the procedure of pre-analytical, analytical and post-analytical microbiology anaerobic sent to 53 Belgium, universities and laboratories of non-university hospitals. Answer of 34 participating laboratories revealed great diversity in all stages of anaerobic microbiological analysis.

Whether or not the type of colonies were identified mainly based on the origin of anatomical samples, colony morphology, and the number of isolates of anaerobic different in the sample, while reporting the results of isolates and to test the susceptibility of anti-microbial mainly based on the origin of the anatomy of the sample, the number of isolates of anaerobic different, and identification anaerobic bacteria. These various inspection procedures, especially expert-based and has not been widely validated clinically. For this reason, a standard, clinically oriented, and feasible procedure for inspection of anaerobic culture developed, using MALDI-TOF MS identification, based on data from the literature and guidelines.

collaborative learning, in which students work together toward a common understanding of the concept, is a well-established pedagogy, and one that has huge potential for higher education (HE). Through discussion and challenge the ideas of each, learners get richer appreciation for the subject than with the study of solitary or didactic teaching methods.

However, collaborative learning requires some scaffolding by the teacher in order to succeed. collaborative learning can be augmented with the use of Web 2.0 collaborative technologies, such as wikis, blogs and social media. This article reviews some of the use of collaborative learning strategies in teaching Microbiology in HE. Despite the great potential of collaborative learning, evidence of its use in teaching Microbiology is, until now, limited. But the potential for collaborative learning approach to develop independent learners in was quite large, and so collaborative learning should be regarded highly as pedagogy eligible to HE.

WAY 316606
A3932-5 5 mg
EUR 406.00
Description: WAY 316606 is a selective small-molecule inhibitor of secreted frizzled-related protein-1 (sFRP-1) with EC50 value of 0.65 ?M [1].The Wnt signaling has been proved to be a drug target of treatment for metabolic bone diseases such as osteoporosis.

WAY 316606
A3932-50 50 mg
EUR 1241.00
Description: WAY 316606 is a selective small-molecule inhibitor of secreted frizzled-related protein-1 (sFRP-1) with EC50 value of 0.65 ?M [1].The Wnt signaling has been proved to be a drug target of treatment for metabolic bone diseases such as osteoporosis.

WAY 316606
HY-10858 5mg
EUR 471.00

WAY 316606 HCl
B8302-10 10 mg
EUR 586.00
Description: WAY 316606 is a selective small-molecule inhibitor of secreted frizzled-related protein-1 (sFRP-1) with EC50 value of 0.65 ?M [1].The Wnt signaling has been proved to be a drug target of treatment for metabolic bone diseases such as osteoporosis.

WAY 316606 HCl
B8302-100 100 mg
EUR 1958.00
Description: WAY 316606 is a selective small-molecule inhibitor of secreted frizzled-related protein-1 (sFRP-1) with EC50 value of 0.65 ?M [1].The Wnt signaling has been proved to be a drug target of treatment for metabolic bone diseases such as osteoporosis.

WAY 316606 HCl
B8302-5 5 mg
EUR 406.00
Description: WAY 316606 is a selective small-molecule inhibitor of secreted frizzled-related protein-1 (sFRP-1) with EC50 value of 0.65 ?M [1].The Wnt signaling has been proved to be a drug target of treatment for metabolic bone diseases such as osteoporosis.

WAY 316606 HCl
B8302-50 50 mg
EUR 1241.00
Description: WAY 316606 is a selective small-molecule inhibitor of secreted frizzled-related protein-1 (sFRP-1) with EC50 value of 0.65 ?M [1].The Wnt signaling has been proved to be a drug target of treatment for metabolic bone diseases such as osteoporosis.

WAY-100635
A3933-10 10 mg
EUR 155.00
Description: 5-HT1A receptors mediate various serotonergic functions and may be implicated in various pathologies including depressive and anxiety disorders, Alzheimer?s disease, and schizophrenia.

WAY-100635
A3933-200 200 mg
EUR 766.00
Description: 5-HT1A receptors mediate various serotonergic functions and may be implicated in various pathologies including depressive and anxiety disorders, Alzheimer?s disease, and schizophrenia.

WAY-100635
A3933-50 50 mg
EUR 466.00
Description: 5-HT1A receptors mediate various serotonergic functions and may be implicated in various pathologies including depressive and anxiety disorders, Alzheimer?s disease, and schizophrenia.

WAY 170523
A4442-1 1 mg
EUR 268.00
Description: Description:IC50: 17 nm (MMP-13)Collagenase 3 is an enzyme that in humans is encoded by the MMP13 gene.

WAY 170523
A4442-10 10 mg
EUR 519.00
Description: Description:IC50: 17 nm (MMP-13)Collagenase 3 is an enzyme that in humans is encoded by the MMP13 gene.

WAY-170523
9607-1
EUR 185.00

WAY-170523
9607-5
EUR 588.00

WAY 213613
B7139-10 10 mg
EUR 389.00

WAY 213613
B7139-50 50 mg
EUR 1476.00

WAY 200070
B7386-10 10 mg
EUR 202.00

WAY 200070
B7386-25 25 mg
EUR 393.00

WAY 200070
B7386-5 5 mg
EUR 131.00

WAY 200070
B7386-50 50 mg
EUR 615.00

WAY-600
B1641-10 10 mg
EUR 350.00
Description: WAY-600 is a potent, ATP-competitive and selective inhibitor of mTOR with IC50 of 9 nM; blocks mTORC1/P-S6K(T389) and mTORC2/P-AKT(S473) but not P-AKT(T308); selective for mTOR than PI3K? (>100-fold) and PI3K? (>500-fold).

WAY-600
B1641-200 200 mg
EUR 2217.00
Description: WAY-600 is a potent, ATP-competitive and selective inhibitor of mTOR with IC50 of 9 nM; blocks mTORC1/P-S6K(T389) and mTORC2/P-AKT(S473) but not P-AKT(T308); selective for mTOR than PI3K? (>100-fold) and PI3K? (>500-fold).

WAY-600
B1641-5 5 mg
EUR 268.00
Description: WAY-600 is a potent, ATP-competitive and selective inhibitor of mTOR with IC50 of 9 nM; blocks mTORC1/P-S6K(T389) and mTORC2/P-AKT(S473) but not P-AKT(T308); selective for mTOR than PI3K? (>100-fold) and PI3K? (>500-fold).

WAY-600
B1641-5.1 10 mM (in 1mL DMSO)
EUR 398.00
Description: WAY-600 is a potent, ATP-competitive and selective inhibitor of mTOR with IC50 of 9 nM; blocks mTORC1/P-S6K(T389) and mTORC2/P-AKT(S473) but not P-AKT(T308); selective for mTOR than PI3K? (>100-fold) and PI3K? (>500-fold).

WAY-600
B1641-50 50 mg
EUR 837.00
Description: WAY-600 is a potent, ATP-competitive and selective inhibitor of mTOR with IC50 of 9 nM; blocks mTORC1/P-S6K(T389) and mTORC2/P-AKT(S473) but not P-AKT(T308); selective for mTOR than PI3K? (>100-fold) and PI3K? (>500-fold).

WAY-600
B1641-S Evaluation Sample
EUR 81.00
Description: WAY-600 is a potent, ATP-competitive and selective inhibitor of mTOR with IC50 of 9 nM; blocks mTORC1/P-S6K(T389) and mTORC2/P-AKT(S473) but not P-AKT(T308); selective for mTOR than PI3K? (>100-fold) and PI3K? (>500-fold).

WAY-600
B1731-1
EUR 153.00

WAY-600
B1731-5
EUR 349.00

WAY-262611
B4818-10 10 mg
EUR 184.00

WAY-262611
B4818-5.1 10 mM (in 1mL DMSO)
EUR 205.00

WAY-262611
B4818-50 50 mg
EUR 506.00

WAY-100635
HY-10349 5mg
EUR 131.00

WAY-213613
HY-107523 5mg
EUR 291.00

WAY-200070
HY-101271 10mM/1mL
EUR 172.00

WAY-262611
HY-11035 10mM/1mL
EUR 235.00

WAY-100635
E1KS2659 10mg
EUR 521.00

WAY-600
E1KS2689 5mg1​ PHYSICAL AND CHEMICAL PROPERTIES
EUR 1111.00

WAY-151932
HY-19381 10mg
EUR 2419.00

WAY-204688
HY-19498 5mg
EUR 1634.00

WAY-600
HY-15272 10mg
EUR 408.00

WAY 629 hydrochloride
B6958-10 10 mg
EUR 284.00

WAY 629 hydrochloride
B6958-50 50 mg
EUR 1038.00

WAY 207024 dihydrochloride
B7525-10 10 mg
EUR 480.00
Description: WAY 207024 dihydrochloride is a potent gonadotropin releasing hormone receptor (GnRH-R) antagonist with IC50 values of 12 and 71 nM for human and rat GnRH receptors, respectively [1].

WAY 208466 dihydrochloride
B7531-10 10 mg
EUR 241.00

WAY 208466 dihydrochloride
B7531-25 25 mg
EUR 485.00

WAY 208466 dihydrochloride
B7531-5 5 mg
EUR 154.00

WAY 267464 dihydrochloride
B7538-10 10 mg
EUR 464.00

WAY 161503 hydrochloride
B6859-10 10 mg
EUR 224.00

WAY 161503 hydrochloride
B6859-5 5 mg
EUR 154.00

WAY 161503 hydrochloride
B6859-50 50 mg
EUR 746.00

WAY-100635 hydrochloride
B2272-25
EUR 370.00

WAY-100635 hydrochloride
B2272-5
EUR 142.00

WAY-100635 Maleate
HY-10349A 5mg
EUR 131.00

WAY-213613 (hydrochloride)
HY-107523A 10mM/1mL
EUR 252.00

(S)-WAY 100135 dihydrochloride
B6659-10 10 mg
EUR 318.00
Description: (S)-WAY 100135 dihydrochloride is a potent and selective antagonist of 5-HT1A receptor with IC50 value of 15 nM. The 5-HT1A receptor is a G protein-coupled receptor for endogenous neurotransmitter serotonin (5-HT) and mediates inhibitory neurotransmission.

(S)-WAY 100135 dihydrochloride
B6659-50 50 mg
EUR 1178.00
Description: (S)-WAY 100135 dihydrochloride is a potent and selective antagonist of 5-HT1A receptor with IC50 value of 15 nM. The 5-HT1A receptor is a G protein-coupled receptor for endogenous neurotransmitter serotonin (5-HT) and mediates inhibitory neurotransmission.

WAY-100635 maleate salt
B2260-10 10 mg
EUR 155.00
Description: WAY 100635 is a potent and selective 5-HT1A receptor agonist with pIC50 of 8.87, exhibits >100-fold selectivity against other 5-HT receptor subtypes and major neurotransmitter receptors.

WAY-100635 maleate salt
B2260-200 200 mg
EUR 766.00
Description: WAY 100635 is a potent and selective 5-HT1A receptor agonist with pIC50 of 8.87, exhibits >100-fold selectivity against other 5-HT receptor subtypes and major neurotransmitter receptors.

WAY-100635 maleate salt
B2260-50 50 mg
EUR 466.00
Description: WAY 100635 is a potent and selective 5-HT1A receptor agonist with pIC50 of 8.87, exhibits >100-fold selectivity against other 5-HT receptor subtypes and major neurotransmitter receptors.

WAY-100635 maleate salt
B2260-S Evaluation Sample
EUR 81.00
Description: WAY 100635 is a potent and selective 5-HT1A receptor agonist with pIC50 of 8.87, exhibits >100-fold selectivity against other 5-HT receptor subtypes and major neurotransmitter receptors.

WAY-100635 (maleate salt)
HY-13105 100mg
EUR 843.00

4-Way Tube Racks, Natural Color
LC8009-105 5/Pk
EUR 138.00

4-Way Tube Racks, Blue Color
LC8009-205 5/Pk
EUR 138.00

4-Way Tube Racks,Green Color
LC8009-305 5/Pk
EUR 138.00

4-Way Tube Racks, Pinkl Color
LC8009-405 5/Pk
EUR 138.00

4-Way Tube Racks, Yellow Color
LC8009-505 5/Pk
EUR 138.00
Scroll to Top